Quick Takeaways
- This page summarizes Eric Benevich's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 10 Jan 2023, 16:13.
Eric Benevich - 06 Jan 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)
- Signature
- /s/ Darin Lippoldt, Attorney-in-Fact
- Issuer symbol
- NBIX
- Transactions as of
- 06 Jan 2023
- Net transactions value
- -$50,000
- Form type
- 4
- Filing time
- 10 Jan 2023, 16:13:51 UTC
- Previous filing
- 01 Dec 2022
- Next filing
- 02 Feb 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Eric Benevich filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 10 Jan 2023."
What Changed
- Previous filing in this sequence was filed on 01 Dec 2022.
- Current net transaction value: -$50,000.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NBIX | Common Stock | Options Exercise | $17,296 | +400 | +2.6% | $43.24 | 16,043 | 06 Jan 2023 | Direct | |
| transaction | NBIX | Common Stock | Sale | $50,000 | -400 | -2.5% | $125.00 | 15,643 | 06 Jan 2023 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NBIX | Non-Qualified Stock Option | Options Exercise | $17,296 | -400 | -0.75% | $43.24 | 53,143 | 06 Jan 2023 | Common Stock | 400 | $43.24 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. |
| F2 | Option granted February 06, 2017 and vested monthly over four years. |